Abstract
Cholangiocarcinoma (CCA) is a severe cancer with poor prognosis. The aim of the present study was to explore the expression of argininosuccinate synthetase (ASS), as well as the possibility of using pegylated arginine deiminase (ADI-PEG20) for the treatment of CCA. ASS expression was determined in CCA specimens from 40 patients in Thailand. Immunohistochemical detection of ASS and determination of the proliferative index, Ki-67, were carried out in paraffin-embedded sections of these specimens, as well as in two CCA cell lines, HuCCA and RmCCA-1, derived from CCA samples from patients in Thailand. In total, ~45% of the CCA specimens had low ASS expression, and the level of expression was significantly negatively associated with cell differentiation (P<0.05) and Ki-67 expression (P<0.05). The level of ASS expression in tumor cells was significantly lower than that in non-tumor cells (1.3-fold, P<0.05). The HuCCA cell line had significantly lower levels (P<0.05) of ASS expression at the mRNA and protein levels relative to those of normal human immortalized fibroblast cells (BJ-1). By contrast, the RmCCA-1 cell line showed no significant difference. In addition, the effects of ADI-PEG20 on growth inhibition, apoptosis and cell cyc...Continue Reading
References
Aug 30, 2000·Virchows Archiv : an International Journal of Pathology·S HorieT Terada
Oct 31, 2006·World Journal of Gastroenterology : WJG·Panthip RattanasinganchanRutaiwan Tohtong
Nov 11, 2006·International Journal of Cancer. Journal International Du Cancer·Cheol-Yong YoonBon-Hong Min
May 14, 2008·Current Pharmaceutical Design·L FeunN Savaraj
Jul 29, 2008·International Journal of Cancer. Journal International Du Cancer·Tawnya L BowlesRichard J Bold
Feb 21, 2009·Journal of the American College of Surgeons·Murad AljiffryMichele Molinari
Mar 6, 2009·Oncology·Tomohiro IguchiMasazumi Tsuneyoshi
Mar 17, 2010·Biochemical and Biophysical Research Communications·Min YouLynn Feun
May 13, 2010·Current Molecular Medicine·N SavarajL G Feun
Oct 15, 2010·Annals of Surgical Oncology·Yoshiaki MurakamiTaijiro Sueda
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Apr 5, 2011·Nature Reviews. Gastroenterology & Hepatology·Tushar Patel
Apr 16, 2011·Scandinavian Journal of Surgery : SJS : Official Organ for the Finnish Surgical Society and the Scandinavian Surgical Society·S Friman
Mar 8, 2012·Current Opinion in Gastroenterology·Jesper B Andersen, Snorri S Thorgeirsson
Aug 23, 2012·World Journal of Gastroenterology : WJG·Chariya HahnvajanawongWichittra Tassaneeyakul
Jan 1, 2010·Oncology Letters·Hua YangRou Li Zhou
Jul 28, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Kritiya ButthongkomvongOn-Usa Sukhontharot
Aug 28, 2013·Molecular Cancer Therapeutics·Yan LongMacus Tien Kuo
Oct 15, 2013·Journal of Surgical Oncology·Suzanne C SchiffmanRobert C G Martin
Jan 24, 2014·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Melissa M PhillipsPeter W Szlosarek
Jun 18, 2014·Cancer Biomarkers : Section a of Disease Markers·Wei ZhaoYun Lu
Jun 20, 2014·Journal of Proteome Research·Gek San TanMaxey Ching Ming Chung
Aug 29, 2014·BMC Cancer·Jennifer A McAlpineJames A Thomson
Sep 23, 2014·BMC Cancer·Jiangbo LiuQingyong Ma
Dec 31, 2014·Journal of Cancer Research and Clinical Oncology·Ann E WaltsSandra Orsulic
Mar 10, 2015·Oncotarget·Niramol SavarajLynn G Feun
Oct 21, 2015·PLoS Pathogens·Michael J SmoutAlex Loukas
Oct 29, 2015·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Sasan MosadeghiRobert J Wong
Jul 28, 2016·Cell Reports·Matthew LockeSarah A Martin
Apr 8, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emma BeddowesPeter W Szlosarek
Jun 8, 2017·International Journal of Molecular Sciences·Angkana ThongkumNiramol Savaraj